02/05/2019 - 3:00pm to 4:30pm
Old Scripps Building Room 10
Location: Old Scripps Building, Room 10
Abstract: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) federal funding programs promote commercialization of research outcomes and facilitate private/public partnerships in the United States. These programs enable small businesses to engage in research and development that has the potential for commercialization and public benefit and support early stage businesses as they are transitioning out of the university. The programs are one of the largest sources of early-stage U.S. technology financing and are a great option for early stage financing of a small business.
Dr Greenberg will share his story, transitioning his research from UC Irvine to a new small business based in San Diego as well as lessons learned in winning over $5 Million dollars in SBIR and other grant funding. Dr Greenberg will also touch on business and equity basics, intellectual property, and commercialization strategies. You should attend if you are considering starting your own business and seeking grant funding or looking for opportunities to fund collaborative research with an external small business.
Speaker Bio: Dr. Greenberg is a co-founder and the President of Vivreon Biosciences, a startup preclinical-stage pharmaceutical company founded in Sorrento Valley in 2014. Dr. Greenberg’s research interest is the discovery and development of small molecule ion channel inhibitors to solve unmet needs in chronic diseases. He is the Principle Investigator on all Vivreon grants, including awards from the National Cancer Institute, National Institute on Aging, National Institute of Allergy and Infectious Diseases, Alzheimer’s Drug Discovery Foundation, Michael J. Fox Foundation, and Johnson and Johnson Innovation.
Dr. Greenberg is also an Assistant Adjunct Professor in the Department of Physiology and Biophysics at the University of California, Irvine School of Medicine, where he serves as the course director for the Medical Physiology and Medical Immunology courses. At UCI, he is a fellow of the Medical Innovation Institute Council, which promotes commercialization of UCI’s medical technology.
For more information on this event, contact: